In summary, four MRBs, including AMDHD1, FMO1, LPL, and P4HA1, were identified and demonstrated good ability in distinguishing patients with NAFLD from HCs. This evidence concerns the gene P4HA1 and metabolic dysfunction-associated steatotic liver disease.